A 24-WEEK RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF INTRANASAL ADMINISTRATION OF 186 AND 372 MCG OF OPN-375 TWICE A DAY (BID) IN SUBJECTS WITH CHRONIC RHINOSINUSITIS WITHOUT THE PRESENCE OF NASAL POLYPS

Registry ID

OPN-FLU-CS-3206

Source registry

HEALTH_CANADA

Status

Pending

Study type

INTERVENTIONAL

Sponsor

OPTINOSE US INC

Last update

2021-05-27

Conditions

• RHINOSINUSITIS

Related clinical trials

• A DOUBLE-BLINDED EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF ITEPEKIMAB IN ADULT PARTICIPANTS WITH INADEQUATELY CONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) WHO PARTICIPATED IN EITHER EFC18418 OR EFC18419 CLINICAL STUDIES
• THE EFFICACY OF INTRA-SINUS POVIDONE-IODINE/BUDESONIDE GEL FORMING SUSPENSION FOLLOWING ENDOSCOPIC SINUS SURGERY FOR CHRONIC RHINOSINUSITIS: A RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, 52-WEEK PHASE 3 TRIAL TO INVESTIGATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ITEPEKIMAB IN ADULT PARTICIPANTS WITH INADEQUATELY-CONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, 52-WEEK PHASE 3 TRIAL TO INVESTIGATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ITEPEKIMAB IN ADULT PARTICIPANTS WITH INADEQUATELY-CONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
• OPENING THE 'BLACK BOX' ON TEZEPELUMAB'S EFFECT OF CHRONIC RHINOSINUSITIS WITH SEVERE ASTHMA
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF-OF-CONCEPT (POC) STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF ITEPEKIMAB IN PARTICIPANTS WITH INADEQUATELY CONTROLLED CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS

View on source registry